Farmavita has developed Renarthro, the synergistic combination of frankincense and myrrh extracts, with Osteol. Renarthro is formulated into capsules, ice-gel and honey. This unique innovative product is available for exclusive licensing or distributorship, for selected markets. Product details are available at www.renarthro.com or please send inquiry to email@example.com.
For centuries traditional medicine has been using the aromatic raisins of frankincense and myrrh to cure various chronic inflammatory diseases. The Bible, Egyptian papyruses, the Vedas and the Koran all mention frankincense and myrrh.The Magi- Casper, Melchior and Balthazar offered frankincense and myrrh to baby Jesus as a gift. At that time, these were the most prized gifts alongside gold.
Modern science has proven that frankincense contains boswellic acid, which has strong anti-inflammatory and analgesic properties. It has also been proven that myrrh extract contains active ingredients which prevent the action of enzymes(collagenase, hyaluronidase), responsible for cartilage breakdown and degeneration.
Osteol™ is a specific bioactive milk protein, researched and patented by the French company Nexira. In clinical trials Osteol has been proven effective and to have significant synergetic action in combination with other anti-arthritic ingredients.
Renarthro is formulated to quickly alleviate pain, decrease inflammations and preserve joint health.
This combination of frankincense and myrrh extracts and Osteol is unique world-wide and under a patent. The innovation which Farmavita d.o.o. has protected by a patent lies in that the efficacy of Renarthro is not a simple sum of the effects of the individual components, but rather synergy whereby the effects of each ingredient are multiplied in combination with the other ingredients.
More details at www.renarthro.com
|Pharma licensing||Out-licensing (offer)|